Based on the findings of our study, the effect of tirofiban was not significantly modified by age, sex, ASPECTS, time from onset to puncture, use of t-PA or stroke etiology, which provided further support for the benefit of tirofiban in AIS patients, regardless of the baseline characteristics. Here, PLAT is linked to androgen insensitivity syndrome.